OSN New York Retina Meeting

Program

8:00 am – 9:00 am

Breakfast Seminar

9:00 am – 9:05 am

Welcome Message
Rishi P. Singh, MD

9:05 am – 10:10 am

Retinal Surgery
Session Chairs: Ronald C. Gentile, MD, FACS, FASRS; Paul Hahn, MD, PhD

Pretest

Management of the Retained Lens Fragment
Andrew A. Moshfeghi, MD, MBA

Aphakia and IOL Dislocation Management
Anton Orlin, MD

Treatment Patterns of Retinal Detachment Repair: The Friday Syndrome?
Prithvi Mruthyunjaya, MD, MHS

When to go Fancy (and When NOT to) in Macular Hole Surgery
Yasha S. Modi, MD

Panel Discussion/Q&A

10:10 am – 10:25 am

Exhibit Hall Break

10:25 am – 11:40 am

Retinal Surgery (Continued)
Session Chairs: Ronald C. Gentile, MD, FACS, FASRS; Paul Hahn, MD, PhD

Techniques for PVR Surgery and When to Retinectomy
Ronald C. Gentile, MD, FACS, FASRS

Lamellar Holes: When to Intervene and When to Observe
Stanley Chang, MD

Complex Tractional Retinal Detachments in Diabetics: Pearls and Outcomes
Dimitra Skondra, MD, PhD

An Update on 3D and Intraoperative OCT in Retinal Surgery
Lejla Vajzovic, MD

Chromovitrectomy: The Old and the New
Paul Hahn, MD, PhD

Discussion, Q&A and Posttest

11:40 am – 12:15 pm

Case Conference: Retinal Surgery
Session Chairs: Donald J. D’Amico, MD; Kenneth J. Wald, MD
Session Panel: Royce W. S. Chen, MD; Peter E. Weseley, MD

12:15 pm – 12:20 pm

Break

12:20 pm – 1:20 pm

CME Lunch Seminar: Eye On Expanding Surgical Systems That Lengthen Treatment Intervals in nAMD and DME

  • Supported by an educational grant from Genentech, a member of the Roche Group
1:20 pm – 1:35 pm

Exhibit Hall Break

1:35 pm – 3:00 pm

Diabetic Retinopathy and Diabetic Macular Edema
Session Chair: Anton Orlin, MD

Pretest

Are Diabetic Retinopathy Practice Patterns Really Impacted by Clinical Trials?
Prithvi Mruthyunjaya, MD, MHS

Imaging in DR: Biomarkers in DR and DME Treatment
Rishi P. Singh, MD

Emerging Therapies in the Treatment of DR and DME
Avnish Deobhakta, MD

Ultrawidefield Fundus Imaging and Application to Diabetic Retinopathy
Szilard Kiss, MD

Ang-2 Inhibition in the Management of DME
Jonathan Jonisch, MD

What Happens to DR Stage When You Stop Anti-VEGF Therapy
Sophie J. Bakri, MD

Discussion/Q&A

3:00 pm – 3:35 pm

Case Conference: Retinal Vascular Disease
Session Chairs: Prithvi Mruthyunjaya, MD, MHS; Lawrence A. Yannuzzi, MD
Session Panel: Talia R. Kaden, MD; Nitish Mehta, MD; Thanos Papakostas, MD

3:35 pm – 3:50 pm

Exhibit Hall Break

3:50 pm – 5:20 pm

OSN’s Disruptive Innovations Symposium**

5:20 pm – 6:00 pm

Meet the Faculty Reception*

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York Retina 2021 or its accredited provider.

8:00 am – 9:00 am

Breakfast Seminar

9:00 am – 9:15 am

Exhibit Hall Break

9:15 am – 11:00 am

Age-related Macular Degeneration
Session Chairs: Sophie J. Bakri, MD; Rishi P. Singh, MD

Announcements and Pretest

Submacular Hemorrhage: Clinic or OR? What Does the Data Support?
Sophie J. Bakri, MD

AI for Detecting AMD and Progression of Disease
Rishi P. Singh, MD

Sustained Drug Delivery for AMD
Jorge A. Fortun, MD

Assessing OCT Biomarkers for Geographic Atrophy
Nitish Mehta, MD

Emerging Therapies for the Treatment of GA
Caroline R. Baumal, MD

Managing Refractory Disease in AMD
Jorge Fortun, MD

Gene Therapy for Exudative AMD
Cagri G. Besirli, MD, PhD

What Does Metformin Have to do with AMD? More Than You Think
Dimitra Skondra, MD, PhD

Discussion, Q&A and Posttest

11:00 am – 11:15 am

Exhibit Hall Break

11:15 am – 11:50 am

Case Conference: Macular Disease
Session Chairs: Caroline R. Baumal, MD; Yasha S. Modi, MD
Session Panel: Eric D. Nudleman, MD, PhD; David Sarraf, MD; Rishi P. Singh, MD

11:50 am – 12:05 pm

Break

12:05 pm – 1:05 pm

Lunch Seminar

1:05 pm – 1:20 pm

Exhibit Hall Break

1:20 pm – 2:55 pm

Imaging
Session Chairs: Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA; Nitish Mehta, MD

Pretest

Epiretinal Membrane: Mechanisms in the Development and Progression using Advanced Retinal Imaging
David Sarraf, MD

Non-perfusion (and Reperfusion) with Anti-VEGF Management in DR
Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA

How Imaging Helps Me Diagnose and Follow Patients with Uveitis
Yasha S. Modi, MD

Polypoidal Choroidal Vasculopathy and the Pachychoroid Spectrum
Lawrence A. Yannuzzi, MD

OCT and OCTA Biomarkers in AMD: What Should We Take Back to the Clinic
Thanos Papakostas, MD

Defining the Role of OCTA in AMD
David Sarraf, MD

Widefield OCT: What, How, and Now
Andrew A. Moshfeghi, MD, MBA

Discussion, Q&A and Posttest

2:55 pm – 3:30 pm

Case Conference: How Imaging Helped to Seal the Diagnosis
Session Chair: Yasha S. Modi, MD; Eric D. Nudleman, MD, PhD
Session Panel: Thanos Papakostas, MD; David Sarraf, MD

3:30 pm – 3:40 pm

Break

3:40 pm – 4:30 pm

Controversies in Care
Session Chairs: Lejla Vajzovic, MD; Peter E. Weseley, MD

Epiretinal Membranes: Early Treatment or Watchful Waiting
Meenakashi Gupta, MD

Fovea-Sparing Rhegmatogenous RD Repair Timing: Is it an Emergency?
Talia Kaden, MD

Complete vs. Limited Vitreous Shaving for RRD Repair: What is Necessary?
Lejla Vajzovic, MD

Why Do We Even Talk About Fluid in AMD?
Darius M. Moshfeghi, MD

Discussion and Q&A

4:30 pm – 5:30 pm

Business of Retina and Practice Management
Session Chairs: Vaidehi Dedania, MD; Philip J. Ferrone, MD

Private Equity in Retina: Evaluating the PE Model
Philip J. Ferrone, MD

Has COVID-19 Changed the Practice of Retina (Forever)?
Darius M. Moshfeghi, MD

Optimizing Workflow in Retina Clinic
Caroline R. Baumal, MD

Retina Practice Implementation of E/M Changes and Guidelines
Mary Pat Johnson, COMT, CPC, COE, CPMA

Discussion/Q&A

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York Retina 2021 or its accredited provider.

8:00 am – 9:00 am

CME Breakfast Seminar: Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: A New Approach to Treatment

  • Supported by an educational grant from Genentech, a member of the Roche Group
    Moderator: Rishi P. Singh, MD
9:00 am – 10:00 am

Pediatric Retina
Session Chairs: Cagri G. Besirli, MD, PhD; Vaidehi S. Dedania, MD; Eric D. Nudleman, MD, PhD

Announcements and Pretest

RD Repair in Self-inflicted Trauma
Vaidehi Dedania, MD

Anti-VEGF for ROP: Role of Adjunct Laser
Cagri G. Besirli, MD, PhD

Pediatric Retinal Conditions Seen in Adults
Eric D. Nudleman, MD, PhD

Cases in Pediatric Retina and Q&A

10:00 am – 10:20 am

Exhibit Hall Break

10:20 am – 11:40 am

Uveitis
Session Chairs: Debra A. Goldstein, MD, FRCS; Yasha S. Modi, MD

Vitreoretinal Lymphoma: When to Suspect This and How to Diagnose
Prithvi Mruthyunjaya, MD, MHS

How to NOT Miss Infectious Uveitis
Debra A. Goldstein, MD, FRCSC

Preventing Endophthalmitis After Intravitreal Injection: What Do We Know
Vaidehi S. Dedania, MD

Uveitis for the Retina Surgeon: When to Intervene and When to Treat in the Clinic
Debra A. Goldstein, MD, FRCSC

New Directions for Local Control of Intraocular Inflammation

10 Pearls When Employing Steroid Sparing Therapy for Noninfectious Uveitis
Debra A. Goldstein, MD, FRCSC

Discussion, Q&A and Posttest

11:40 am – 12:40 pm

CME Seminar: Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: A New Approach to Treatment

  • Supported by an educational grant from Apellis
    Moderator: Caroline Baumal, MD
    Nathan C. Steinle, MD
12:40 pm – 1:15 pm

Case Conference: Uveitis
Session Chair: Debra Goldstein, MD, FRCSC
Session Panel: Yasha S. Modi, MD

1:15 pm

Closing Remarks & Lunches to Go

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York Retina 2021 or its accredited provider.